Nicholas Kadysh - Net Worth and Insider Trading
Nicholas Kadysh Net Worth
The estimated net worth of Nicholas Kadysh is at least $21,250 dollars as of 2024-09-21. Nicholas Kadysh is the Director, Senior Officer of Pharmala Biotech Holdings Inc and owns about 250,000 shares of Pharmala Biotech Holdings Inc (XCNQ:MDMA) stock worth over $21,250. Details can be seen in Nicholas Kadysh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicholas Kadysh has not made any transactions after 2023-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nicholas Kadysh
Nicholas Kadysh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicholas Kadysh owns 1 companies in total, including Pharmala Biotech Holdings Inc (XCNQ:MDMA) .
Click here to see the complete history of Nicholas Kadysh’s form 4 insider trades.
Insider Ownership Summary of Nicholas Kadysh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:MDMA | Pharmala Biotech Holdings Inc | 2023-03-28 | Director & Senior Officer |
Nicholas Kadysh Latest Holdings Summary
Nicholas Kadysh currently owns a total of 1 stock. Nicholas Kadysh owns 250,000 shares of Pharmala Biotech Holdings Inc (XCNQ:MDMA) as of March 28, 2023, with a value of $21,250.
Latest Holdings of Nicholas Kadysh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:MDMA | Pharmala Biotech Holdings Inc | 2023-03-28 | 250,000 | 0.09 | 21,250 |
Holding Weightings of Nicholas Kadysh
Nicholas Kadysh Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicholas Kadysh has made a total of 3 transactions in Pharmala Biotech Holdings Inc (XCNQ:MDMA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Pharmala Biotech Holdings Inc is the acquisition of 100,000 shares on March 28, 2023, which cost Nicholas Kadysh around $18,500.
Insider Trading History of Nicholas Kadysh
- 1
Nicholas Kadysh Trading Performance
GuruFocus tracks the stock performance after each of Nicholas Kadysh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicholas Kadysh is 144.25%. GuruFocus also compares Nicholas Kadysh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicholas Kadysh within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nicholas Kadysh's insider trading performs compared to the benchmark.
Performance of Nicholas Kadysh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 159.15 | | | | | |
| Relative Return to S&P 500(%) | 157.45 | | | | | |
Nicholas Kadysh Ownership Network
Nicholas Kadysh Owned Company Details
What does Pharmala Biotech Holdings Inc do?
Who are the key executives at Pharmala Biotech Holdings Inc?
Nicholas Kadysh is the Director & Senior Officer of Pharmala Biotech Holdings Inc. Other key executives at Pharmala Biotech Holdings Inc include and Director & Senior Officer Shane H.D. Morris .
Pharmala Biotech Holdings Inc (XCNQ:MDMA) Insider Trades Summary
Over the past 18 months, Nicholas Kadysh made 1 insider transaction in Pharmala Biotech Holdings Inc (XCNQ:MDMA) with a net purchase of 100,000. Other recent insider transactions involving Pharmala Biotech Holdings Inc (XCNQ:MDMA) include a net sale of 646,000 shares made by Shane H.D. Morris ,
In summary, during the past 3 months, insiders sold 0 shares of Pharmala Biotech Holdings Inc (XCNQ:MDMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 646,000 shares of Pharmala Biotech Holdings Inc (XCNQ:MDMA) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 546,000 shares.
Pharmala Biotech Holdings Inc (XCNQ:MDMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pharmala Biotech Holdings Inc Insider Transactions
Nicholas Kadysh Mailing Address
Above is the net worth, insider trading, and ownership report for Nicholas Kadysh. Currently GuruFocus does not have mailing address information for Nicholas Kadysh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
